To meet the medical need of pets, we develop species-specific therapeutic antibodies from our own platform
Location: Germany, Bavaria, Planegg
Total raised: $2.46M
Investors 2
| Date | Name | Website |
| - | OCCIDENT | occident.g... |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.10.2022 | - | $2.46M | - |
Mentions in press and media 5
| Date | Title | Description |
| 15.09.2023 | Veterinary pharmaceuticals company Zoetis buys adivo from Puchheim | U.S.-based veterinary drugmaker Zoetis has acquired Adivo, a biotech company developing therapeutic antibodies for companion animals. adivo will remain in Puchheim, Munich, with more than 1,000 m2 of laboratory space. Financial details were... |
| 20.12.2022 | adivo receives limited market authorization status from European Medicines Agency (EMA) for lead oncology program | adivo GmbH, a Martinsried-based company focussed on discovering species-specific therapeutic antibodies for pets, today announced that the company has been granted the limited market authorization status by the Committee for Veterinary Medi... |
| 18.10.2022 | adivo: EUR 2.5 million EU funding for therapies against inflammatory bowel disease in companion animals | Martinsried-based adivo GmbH has been awarded a €2.5 million European Innovation Council (EIC) Accelerator Grant to support its therapeutic antibody program for novel therapeutic options for dogs with inflammatory bowel disease. adivo aims... |
| 20.08.2018 | Pet Therapeutic Antibody Startup Adivo Closes Seed Financing | adivo, a German biotech company specializing in generating species-specific therapeutic antibodies for companion animals, received a seed financing of undisclosed amount. Backers included High-Tech Gründerfonds (HTGF), Occident Group AG and... |
| - | Pet therapeutic antibody firm adivo announces closure of seed-financing round | German biotech company adivo specializing in generating species-specific therapeutic antibodies for companion animals announces that it received a seed financing from three investors. The adivo team aims to address high medical needs in dog... |